Receipt of in-principle approval from BSE Limited for 20,00,000 Equity Shares of Rs. 10/- each to be issued under "Chemcrux Enterprises Employee Stock Option Scheme 2025"
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemcrux Enterprises has received in-principle approval from BSE to issue up to 20,00,000 (20 lakh) equity shares of Rs. 10 each under its 'Chemcrux Enterprises Employee Stock Option Scheme 2025'. The approval, granted via BSE letter dated February 9, 2026, covers shares that will arise when employees exercise their stock options in line with SEBI's Share Based Employee Benefits and Sweat Equity Regulations, 2021. The company must still comply with conditions including payment of fees, statutory approvals, and post-allotment listing requirements. No shares have been allotted yet — this approval is just a preliminary go-ahead for the future ESOP issuance.
Existing shareholders may face equity dilution of up to 20 lakh shares once employees begin exercising their stock options, which could put mild pressure on earnings per share. However, ESOPs are typically used to attract and retain talent, so the long-term impact depends on the company's growth generating value greater than the dilution.